title: Can protons or altered fractionation decrease neurotoxicity after chemoradiation in head and neck cancer?
authors.affiliation: Hall-Edwards Radiotherapy Research Group, Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK.
authors.forename: H
authors.initials: H
authors.lastname: Benghiat
authors.affiliation: Hall-Edwards Radiotherapy Research Group, Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK.
authors.forename: J
authors.initials: J
authors.lastname: Cashmore
authors.affiliation: Hall-Edwards Radiotherapy Research Group, Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK.
authors.forename: T
authors.initials: T
authors.lastname: Williams
authors.affiliation: Hall-Edwards Radiotherapy Research Group, Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK.
authors.forename: S
authors.initials: S
authors.lastname: Green
authors.affiliation: Hall-Edwards Radiotherapy Research Group, Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK; Institute of Head and Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, UK. Electronic address: andrew.hartley@uhb.nhs.uk.
authors.forename: A
authors.initials: A
authors.lastname: Hartley
authors.affiliation: Hall-Edwards Radiotherapy Research Group, Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK; Institute of Head and Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, UK.
authors.forename: P
authors.initials: P
authors.lastname: Sanghera
mesh_terms: D003072:Cognition Disorders / Q000209:etiology*; D006258:Head and Neck Neoplasms / Q000503:physiopathology* / Q000532:radiotherapy*; D006801:Humans; D011832:Radiation Injuries / Q000209:etiology*